In these sublines, DEVD-amc cleaving activity was also abrogated during stimulation with CD95L in combination with the protein synthesis inhibitor cycloheximide, which sensitizes glioma cells to CD95-mediated apoptosis induction [4]. The gene discussed is FAS; the disease is central nervous system cancer.